EurekaMag
+ Translate
+ Most Popular
Gaucher's disease;thirty-two years experience at Siriraj Hospital
A study of Macrobathra Meyrick from China (Lepidoptera, Cosmopterigidae)
First occurrence in ores of tetragonal chalcocite
Effects of trace element nutrition on sleep patterns in adult women
N.Z. range management guidelines. 2. Design of grazing management systems for tussock country
A case of lipoma of the esophagus
A revision of world Acanthosomatidae (Heteroptera: Pentatomidae): keys to and descriptions of subfamilies, tribes and genera, with designation of types
Life history of the coronate scyphozoan Linuche unguiculata (Swartz, 1788)
Perceptual restoration of obliterated sounds
Mutagenicity studies on two chromium(III) coordination compounds
The formation of the skeleton. I. Growth of a long bone. 1st appearance of a center of calcification
Leucopenia and abnormal liver function in travellers on malaria chemoprophylaxis
The joint commission: four key root causes loom large in sentinel event data
Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A
Behaviour of dairy cows within three hours after feed supply: I. Influence of housing type and time elapsing after feed supply
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Management and control of patients with type 2 diabetes mellitus in Lebanon: results from the International Diabetes Management Practices Study (IDMPS)
The diet composition and nutritional knowledge of patients with anorexia nervosa
Physoporella croatica Herak, 1958 of the Slovak karst Anisian (Slovakia, the West Carpathians Mts.)
Bright lights, big noise. How effective are vehicle warning systems?
Ein Plesiosaurier-Rest mit Magensteinen aus mittlerem Lias von Quedlinburg
Incidence of Chlamydia trachomatis in patients with sterility
Monster soup: the microscope and Victorian fantasy
Preliminary tests with residual sprays against poultry lice
Duration of the life of plants in phylogeny

Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?


Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?



Antimicrobial Agents and ChemoTherapy 39(10): 2197-2200



ISSN/ISBN: 0066-4804

PMID: 8619566

DOI: 10.1128/aac.39.10.2197

A series of fluconazole-susceptible and-fluconazole resistant Candida albicans fungal isolates were used to infect mice intravenously. Mice were treated with varying doses of fluconazole beginning one day after infection. For all of the 6 fluconazole-susceptible isolates, fluconazole was highly effective at <0.25 mg/kg of body weight twice daily. By contrast, fluconazole was less effective in at least 6 of 10 fluconazole-resistant isolates and was ineffective at > or = 40 mg/kg twice daily in 4 fluconazole-resistant isolates. Although the correlation is not precise, in vitro susceptibility testing of C. albicans can predict in vivo response to fluconazole.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008693595

Download citation: RISBibTeXText

Related references

Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Reviews of Infectious Diseases 12(Suppl): S272-S275, 1990

Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrobial Agents and Chemotherapy 44(8): 2081-2085, 2000

Fluconazole resistance in Candida albicans In vivo and in vitro findings in patients with HIV infection. Aids-Forschung. 9(11): 609, 1994

Fluconazole therapy of oropharyngeal candidiasis in a patient with multiple endocrine failure does not correlate with Candida albicans susceptibility to fluconazole in vitro. Journal of Medical and Veterinary Mycology: Bi-Monthly Publication of the International Society for Human and Animal Mycology 34(3): 205-208, 1996

Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans. Antimicrobial Agents and ChemoTherapy 43(12): 2841-2847, 1999

Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection. References 64(1): 78-85, 2021

In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods. Fems Immunology and Medical Microbiology 58(2): 193-201, 2010

Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology Biochemistry and Pharmacology 40(3-4): 727-742, 2016

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 18(2): 240-242, 1994

Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. Journal of Clinical Microbiology 47(6): 1927-1930, 2009

In vitro susceptibility of fluconazole-resistant strains of Candida albicans to itraconazole. Abstracts of the General Meeting of the American Society for Microbiology 94: 607, 1994

In vitro susceptibility of paediatric clinical isolates of Candida albicans to fluconazole and voriconazole. Mycoses 44(Suppl 1): 52, 2001

In vitro susceptibility versus amphotericin B, fluconazole, and itraconazole of 278 isolates of Candida albicans. Revista Iberoamericana de Micologia 9(4): 94-96, 1992

Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance. Antimicrobial Agents and ChemoTherapy 50(2): 580-586, 2006

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo. Antimicrobial Agents and ChemoTherapy 30(3): 418-422, 1986